Sernova Biotherapeutics (SEOVF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 10/31
(Values in U.S. thousands)
| 10-2025 | 10-2024 | 10-2023 | 10-2022 | 10-2021 | |
| Operating Expenses | 10,725 | 23,263 | 30,028 | 19,229 | 5,517 |
| Operating Income | -10,725 | -23,263 | -30,028 | -19,229 | -5,517 |
| Other Income | -508 | -383 | 1,115 | 259 | -23 |
| Pre-tax Income | -11,233 | -23,646 | -28,913 | -18,970 | -5,540 |
| Income Tax | -7 | 5 | N/A | N/A | N/A |
| Net Income Continuous | -11,226 | -23,652 | -28,913 | -18,970 | -5,540 |
| Net Income | $-11,239 | $-23,652 | $-28,913 | $-18,970 | $-5,540 |
| EPS Basic Total Ops | -0.04 | -0.07 | -0.10 | -0.07 | -0.02 |
| EPS Basic Continuous Ops | -0.03 | -0.08 | -0.10 | -0.07 | -0.02 |
| EPS Diluted Total Ops | -0.04 | -0.07 | -0.10 | -0.07 | -0.02 |
| EPS Diluted Continuous Ops | -0.03 | -0.08 | -0.10 | -0.07 | -0.02 |
| EPS Diluted Before Non-Recurring Items | -0.04 | -0.07 | -0.10 | -0.07 | -0.02 |
| EBITDA(a) | $-10,480 | $-22,866 | $-29,698 | $-18,887 | $-5,304 |